[Download] The Illustrated Dictionary of Toxicologic Pathology and Safety Science de Pritam S. Sahota,Robert H. Spaet,Philip Bentley,Zbigniew Wojcinski Libros Gratis en EPUB, The Illustrated Dictionary of Toxicologic Pathology and Safety Science Libro pdf espanol
The Illustrated Dictionary of Toxicologic Pathology and Safety Science de Pritam S. Sahota,Robert H. Spaet,Philip Bentley,Zbigniew Wojcinski
Descripción - Reseña del editor There has been a growing interest in toxicologic pathology, especially as related to its impact on the safety assessment of pharmaceuticals and chemicals, and in drug development. Thus, there is a growing need for an Illustrated Dictionary of Toxicology Pathology and Safety Science (IDTP) that this dictionary aims to fill. The language of toxicologic pathology may be less familiar to a broad range of safety scientists, especially those involved in the safety evaluation of pharmaceuticals and chemicals. The IDTP format provides the brevity and clarity that the user is not likely to receive in a textbook, even if adequately indexed. With the inclusion of descriptions for terms used in toxicology, drug metabolism/pharmacokinetics, and regulatory science, the scope of the IDTP is considerably broadened and decidedly unique in its appeal to all safety scientists. With over 800 photos and illustrations to provide visual context,* an important aim of the IDTP is to present pathological changes as reference examples for terminology, nomenclature, and term descriptions for the entry entry-level as well as seasoned toxicologic pathologist. It will also aid students and non-pathology specialists such as study directors, senior toxicology report reviewers, scientific management of contract research organizations, regulatory agencies, and drug development companies to better understand the biological significance of tissue changes. The IDTP provides a single reference volume for these users to further their understanding and appreciation of biologically significant pathology findings. The IDTP consists of four major areas: 1. A-Z Dictionary of Pathology encompassing all organ systems, together with relevant non-pathology terms supported by references in 'For Further Reading' sections. 2. Appendix 1: An Overviews of Drug Development, Nonclinical Safety & Toxicologic Pathology, and Important/Special Topics. 3. Appendix 2: Diagnostic Criteria of for Proliferative Proliferative Lesions in Rodents (Rat and Mouse) and Selected Non-Rodent Laboratory Species containing illustrations with detailed references and links to source material. 4) Appendix 3: Mini-Atlas of Organ System Anatomy and Histology to help re-acquaint the non-pathologist safety scientist with many normal anatomical structures.
The editors and contributing scientists (board-certified veterinary pathologists, board-certified toxicologists, allied health safety scientists, health regulatory representatives) have experience from bench-level pathology and toxicology to managing global preclinical safety units in leading pharmaceutical companies. They have considerable experience mentoring pharmaceutical industry project team members, interacting with industry clinicians and representatives of decision-making bodies within the industry, as well as with global health authorities, such as the FDA and EMA. These activities convinced them of the necessity for and usefulness of the IDTP. As experts in their field, they have undertaken the hard work of writing and compiling the information, making the IDTP an exceptional, go-to reference. *Illustrations Editor: Gregory Argentieri Biografía del autor
Dr. Pritam S. Sahota studied for his Veterinary Medicine (BVSc) and Veterinary Pathology (MSc and PhD) degrees at Punjab Agricultural University in India. He is a Diplomate of the American Board of Toxicology. After completing his PhD, he immigrated to the USA in 1976 and worked for Dawson Research Corporation in Orlando, Florida for 10 years with increasing responsibilities as Toxicologic Pathologist, Senior Toxicologic Pathologist, and Scientific Director. As Scientific Director, he was overall responsible for the Departments of Pathology and Toxicology in this contract research organization (CRO) that was involved in the safety evaluation of drugs and chemicals. While working briefly for Dynamac Corporation in Research Triangle Park, NC (1986-87), Dr. Sahota conducted retrospective scientific audits on 23 NTP carcinogenicity studies and participated in discussions with the representatives of NTP, FDA and EPA to summarize the results of scientific audits of approximately 200 carcinogenicity studies. In 1987, Dr. Sahota joined Ciba-Geigy Pharmaceuticals in Summit, NJ as Head/Manager of Pathologists and helped establish Pathology Peer Review and Quality Control systems. He continued to work primarily in this position with increasing responsibilities in Ciba-Geigy and then Novartis (resulting from Ciba/Sandoz merger in 1997) up to 2000, when he became Head of Pathology (Director? Executive Director: 2000-12, East Hanover, NJ). In addition to his pathology responsibilities, Dr. Sahota also served as an International Project Team Representative for a number of marketed drugs including an antihypertensive blockbuster, Diovan, where he successfully defended company position with the FDA and various International Regulatory Authorities. During 2010-12, he also successfully led following Global Preclinical Safety initiatives at Novartis: Patient Centricity (Patient in the Lab), Cardiotoxicity, Ocular Toxicity, and evaluation of rodent carcinogenicity potential based on short-term toxicity and genotoxicity studies to minimize delays in regulatory submissions. Dr. Sahota also held an adjunct academic appointment of Assistant Professor in the University of Medicine and Dentistry of New Jersey, Newark, NJ for approximately 8 years. In 2013, he also published the book entitled 'Toxicologic Pathology – Nonclinical Safety Assessment' (CRC Press) as Lead Editor. Since 2013, Dr. Sahota has been President of Global ToxPath LLC located in Kennewick, WA (Toxicologic Pathology Consultancy). 2
Robert Spaet obtained his BS and MS degrees in Zoology from Eastern Illinois University (1971, 1973). He began his career as a Sr. Research Technician at the Franklin McClean Memorial Research Institute, University of Chicago, before joining GD Searle Laboratories in Skokie, IL as a Parapathologist (1973-76). He became a Research and Teaching Assistant at the University of Oklahoma Health Sciences Center in Oklahoma City, OK, and completed the coursework towards a PhD in Anatomic and Experimental Pathology (1975-77) before joining Ciba-Geigy Pharmaceuticals in June 1977 as a Scientist II in Pathology, Preclinical Safety. He also completed his oral and written exams for PhD degree in Anatomic Pathology at University of Medicine and Dentistry of New Jersey, Newark, NJ (UMDNJ), in 1984 while working for CIBA. His core training and expertise lies in toxicologic pathology within the framework of drug safety evaluation. He has also had full time experience as a Study Director and is certified as a Diplomate, American Board of Toxicology. He has written many scientific papers in the field of toxicology and toxicologic pathology and holds full membership in several prominent professional societies including the Society of Toxicologic Pathologists (US and Europe), Society of Toxicology, American College of Toxicology, and is a member of the Roundtable of Toxicology Consultants. Robert has 35+ years of experience in toxicologic pathology and regulatory toxicology. During his tenure with CIBA and Novartis (merger of CIBA and Sandoz), he held a series of positions of increasing responsibility to eventually become Director, Translational Sciences, Preclinical Safety, Department of Pathology. His professional experience was broadened as an Exchange Scientist with CIBA in Basel, Switzerland (1987-88). Among other professional activities, he participated in the team teaching of Pathology in the School of Allied Health Sciences at UMDNJ for a number of years. Since 1986 he served as an International Project Team Preclinical Safety representative for a number of compounds in development, including several successfully marketed (blockbuster) pharmaceuticals. Within this capacity he has authored extensive safety summaries in support of IND/NDA/CTX drug submissions and represented the company as a preclinical safety expert before regulatory agencies such as the FDA and EMEA. Post-retirement, Robert continues to remain active in toxicologic pathology and non-clinical safety having established a consultancy RSPathologics, LLC. He is also a member of several high-profile groups including the Society of Toxicologic Pathology’s Science and Regulatory Policy Committee, the STP Membership Committee, and the European Society of Toxicologic Pathology Committee on Future Technologies in Toxicologic Pathology. Zbigniew W. Wojcinski, D.V.M, D.V.Sc., DACVP, DABT is Principal and Co-Founder of Drug Development Preclinical Services, LLC, and has 30 years’ experience in drug development. Dr. Wojcinski received his undergraduate degree (B.Sc.) in Zoology at the University of Toronto and his D.V.M. and D.V.Sc. (Pathology) from the Ontario Veterinary College, University of Guelph. He is a certified Diplomate of the American Board of Toxicology and a Diplomate of the American College of Veterinary Pathologists. He is also recognized as a Specialist in Veterinary Pathology by the Canadian Veterinary Medical Association. Dr. Wojcinski gained experience in drug development and toxicologic pathology with Parke-Davis\Warner-Lambert and Pfizer Global Research and Development over 22 years and then Fulcrum Pharma Developments, Inc. for 3½ years. In 2011, he co-founded Drug Development Preclinical Services, LLC. He has extensive experience as Study Pathologist and Review Pathologist for acute, repeated dose subchronic and chronic oral and intravenous studies, including 5 carcinogenicity studies. Throughout his career, he has managed successful cross-functional drug development teams in CNS, Metabolic Diseases and Dermatology therapeutic areas. As Therapeutic Area Leader for Dermatology at Pfizer, Dr. Wojcinski was responsible for development and implementation of the safety and risk management strategies in this new therapeutic area at Pfizer. He has also been directly involved in the preparation of pre-IND documents, Nonclinical Safety Assessments for IND/IMPD/NDA/MAA, Investigator’s Brochures and labeling (USPI, SmPC) negotiations in CNS, anti-infective, and/or dermatology therapeutic areas. Dr. Wojcinski has had numerous interactions with regulatory agencies in the US, Europe, Canada and Australia for compounds at various stages of development. Most notably, Dr. Wojcinski was the toxicology representative throughout the entire development of the CNS drug, Lyrica®, which is now marketed worldwide. He has also provided pathology consultation and histopathology peer review on several projects in various therapeutic areas, including respiratory infections, dermatitis, and ophthalmic disease. Dr. Wojcinski has authored/co-authored numerous scientific manuscripts and 4 book chapters.
Philip Bentley is Principal Consultant at Toxicodynamix International LLC. He studied biochemistry at the University of Hull, UK, graduating with a BSc in 1970 and a PhD in 1974. He had postdoctoral fellowships at the Universities of Basel. Switzerland and Mainz, Germany. His postdoctoral research centered upon formation and inactivation of reactive metabolites and the enzymes involved in the metabolism of foreign compounds. In 1979 he joined the Investigative Toxicology group (known as Cell Biology) in the Toxicology Department of Ciba-Geigy, Basel, Switzerland and remained with the company, later Novartis, until 2014. In these 35 years he held various management positions in Europe and the USA with responsibility for Investigative Toxicology; Drug Metabolism; Drug Metabolism and Toxicology; Preclinical Safety Europe; Drug Metabolism and Pharmacokinetics; Toxicology/Pathology USA; Preclinical Safety USA and Global Preclinical Safety. In these positions he contributed to the registration of more than 45 marketed drug products and the preparation of several hundred IND’s. He has vast experience in the areas of drug metabolism and disposition, toxicology/pathology, genetic toxicology, pharmacokinetics/toxicokinetics and all aspects of investigative toxicology. He is well grounded in biochemistry, cell biology, molecular biology and pharmacology with the ability to integrate data from the different preclinical disciplines to enable translation to determine the clinical relevance of the findings. He is very familiar with global drug registration requirements and working on global projects. He has authored more than 80 scientific publications, has lectured in toxicology at the University of Basel for more than 30 years, and is a past President of the European Society of Biochemical Pharmacology and the Swiss Society of Toxicology. He was a member of the PhRMA/IQ Preclinical Leadership (DruSafe) Committee for 16 years, a member of the advisory board of the PSTC Biomarker consortium and a member of the expert working group for revision of the ICH S2 guidance on genotoxicity testing and the PhRMA expert group on genotoxic impurities.
Detalles del Libro
- Name: The Illustrated Dictionary of Toxicologic Pathology and Safety Science
- Autor: Pritam S. Sahota,Robert H. Spaet,Philip Bentley,Zbigniew Wojcinski
- Categoria: Libros,Libros universitarios y de estudios superiores,Medicina y ciencias de la salud
- Tamaño del archivo: 16 MB
- Tipos de archivo: PDF Document
- Descargada: 196 times
- Idioma: Español
- Archivos de estado: AVAILABLE
Leer en linea The Illustrated Dictionary of Toxicologic Pathology and Safety Science de Pritam S. Sahota,Robert H. Spaet,Philip Bentley,Zbigniew Wojcinski Libro PDF, ePub, Mobile
The Illustrated Dictionary of Toxicologic Pathology and ~ 配送商品ならThe Illustrated Dictionary of Toxicologic Pathology and Safety Scienceが通常配送無料。更にならポイント還元本が多数。Sahota, Pritam S., Spaet, Robert H., Bentley, Philip, Wojcinski, Zbigniew作品ほか、お急ぎ便対象商品は当日お届けも可能。
The Illustrated Dictionary of Toxicologic Pathology and ~ Thus, there is a growing need for an Illustrated Dictionary of Toxicology Pathology and Safety Science (IDTP) that this dictionary aims to fill. The language of toxicologic pathology may be less familiar to a broad range of safety scientists, especially those involved in the safety evaluation of pharmaceuticals and chemicals.
The Illustrated Dictionary of Toxicologic Pathology and ~ The Illustrated Dictionary of Toxicologic Pathology and Safety Science / There has been a growing interest in toxicologic pathology, especially as related to its impact on the safety assessment of pharmaceuticals and chemicals, and in drug development. Thus, there is a growing need for an Illustrated Dictionary of Toxicology Pathology and Safety Science (IDTP) that this dictionary aims to fill.
Toxicologic Pathology: Nonclinical Safety Assessment ~ Toxicologic Pathology: Nonclinical Safety Assessment, Second Edition includes 2 new concept chapters. The first of the new chapters address approaches for the evaluation of unique therapeutic modalities such as cell therapies, gene therapies, and gene expression knockdown therapies.
Toxicologic Pathology / Taylor & Francis Group ~ Toxicologic Pathology: Nonclinical Safety Assessment, Second Edition includes 2 new concept chapters. The first of the new chapters address approaches for the evaluation of unique therapeutic modalities such as cell therapies, gene therapies, and gene expression knockdown therapies.
Toxicologic Pathology - an overview / ScienceDirect Topics ~ Daniel J. Patrick, Marlon C. Rebelatto, in The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment, 2015. Abstract. Toxicologic pathology plays a critical role in the safety assessment of nonhuman primates used in drug development through the identification and interpretation of microscopic tissue changes. The discrimination between background changes, or those changes that .
Book Review: Toxicologic Pathology, Nonclinical Safety ~ In order to meet the increasing demand to verify the quality of pathological and toxicological assessments in safety testing for chemicals, three board certification systems have been established in Japan in independent categories of science: one for toxicologic pathologists by the Japanese Society of Toxicologic Pathology (JSTP), one for veterinary pathologists by the Japanese College of .
Toxicologic Pathology: SAGE Journals ~ Toxicologic Pathology is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology. Toxicologic Pathology, the official journal of the Society of Toxicologic Pathology, will publish Original Research .
Training of Toxicologic Pathologists ~ of the toxicologic pathology training experience (e.g., how . tions applicable to risk and safety assessment. Such knowledge is necessary for the practice of regulatory-type toxicologic . science disciplines with core clinical concepts and mechan-isms, .
Handbook of Toxicologic Pathology / ScienceDirect ~ In volume I, the book covers toxicologic pathology in its basic aspects, including its definition, the basic biochemical and morphologic mechanisms underlying the discipline, the basic practice of toxicologic pathology (including special techniques) and issues essential to the understanding of toxicologic pathology such as risk assessment, experimental design, and statistical analysis.
Toxicologic Pathology / SAGE Publications Inc ~ Toxicologic Pathology is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology. Toxicologic Pathology, the official journal of the Society of Toxicologic Pathology, the British Society of Toxicological Pathology and the European Society of .
The Society of Toxicologic Pathology (STP ~ The Society of Toxicologic Pathology (STP) was founded in 1971 as a nonprofit association of pathologists and other scientists whose principal aim is the advancement of pathology as it pertains to changes elicited by pharmacological, chemical, or environmental agents, and factotors that modify these responses.
TOXICOLOGIC PATHOLOGY (SAGE ,1972-) / Institución ~ Datos de la revista Título de la revista TOXICOLOGIC PATHOLOGY Editorial SAGE Especialidad MEDICINA LEGAL Y FORENSE Digital Si Años 1972- IP Acceso a la.
Toxicologic Pathology - British Society of Toxicological ~ Toxicologic Pathology is dedicated to the promotion of human health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology. The journal publishes timely high-quality, original research articles that integrate the pathophysiologic effects of exposure to xenobiotics and other toxicants on organisms and organ systems.
Toxicologic pathology : nonclinical safety assessment ~ Overview of drug development / James A. Popp and Jeffery A. Engelhardt --Nonclinical safety evaluation of drugs / Thomas M. Monticello and Jeanine L. Bussiere --Toxicokinetics and drug metabolism : relating toxicity to compound exposure and disposition / David D. Christ --Introduction to toxicologic pathology / Judit E. Markovits [and others .
Toxicologic Pathology / Charles River ~ Toxicologic Pathology Services Charles River operates full-service laboratories with facilities and program/project offices at numerous locations around the globe. All of the facilities are functionally integrated and offer interactive services to fulfill your needs.
Toxicologic Pathology - Wikipedia ~ Toxicologic Pathology is a peer-reviewed academic journalcovering the field of toxicology.The editor-in-chief is Susan A. Elmore (National Toxicology Program/National Institute of Environmental Health Sciences).It was established in 1972 and is published by SAGE Publications in association with the Society of Toxicologic Pathology, the British Society of Toxicological Pathology, and the .
TOXICOLOGY HANDBOOK EBOOK / LINDSAY MURRAY / Descargar ~ Descargar libro TOXICOLOGY HANDBOOK EBOOK del autor LINDSAY MURRAY (ISBN 9780729579391) en PDF o EPUB completo al MEJOR PRECIO, leer online gratis la sinopsis o resumen, opiniones, críticas y comentarios.
Fundamentals of Toxicologic Pathology 2nd EditionDownload ~ Fundamentals of Toxicologic Pathology Second Edition updates the information presented in the first edition, including five entirely new chapters addressing basic concepts in toxicologic pathology, along with color photomicrographs that show examples of specific toxicant-induced diseases in animals.
Toxicologic Pathology - SCImago Journal Rank ~ Toxicologic Pathology focuses on the multidisciplinary elements that constitute toxicologic pathology, including spontaneous and experimentally induced morphological and functional changes, environmental exposures, case reports, and risk assessment and investigative techniques. The journal publishes original articles, symposia papers, .
Archive of "Journal of Toxicologic Pathology". ~ Articles from Journal of Toxicologic Pathology are provided here courtesy of The Japanese Society of Toxicologic Pathology Support Center Support Center External link.
Fundamentals of Toxicologic Pathology - Wanda M. Haschek ~ Fundamentals of Toxicologic Pathology focuses on providing basic information integrated from both toxicology and pathology dealing with the mechanisms of toxic injury and morphologic expression of that injury at the subcellular, cellular, and tissue levels. This text is an enhanced and edited version of the Handbook of Toxicologic Pathology, creating a more concise and affordable text ideal .
Toxicologic Pathology: Nonclinical Safety Assessment - 1st ~ As drug development shifts over time to address unmet medical needs and more targeted therapies are developed, previously unseen pharmacological or off-target effects may occur in treatment. Designed to provide practical information for the bench toxicologic pathologist working in pharmaceutical dru
What is toxicologic pathology exactly? • Nethdd ~ So toxicologic pathology assesses the safety of medication, vaccines, chemicals, and much more. It makes sense that it’s mainly used for the pharmaceutical and chemical industry. Toxicologic pathologists also work in academic institutions, governments, research organizations or they can be employed as consultants.
Journal of Toxicologic Pathology Impact Factor 임팩트 팩터 2018 ~ Journal of Toxicologic Pathology 임팩트 팩터 (Impact Factor, IF): 1.153 (2019 최신 데이터). 피인용지수 혹은 임팩트 팩터(Impact Factor, IF)는 자연과학·사회과학 분야의 학술 잡지를 대상으로 삼고, 그 잡지의 영향도를 재는 지표다. 임팩트 팩터 (Impact Factor, IF)는 2 년 전 (2016-2017) 동안 저널에 발표 된 논문이 특정 .